VTR 📈 Ventas - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92276F1003
VTR: Senior Housing, Medical Buildings, Research Centers, Healthcare Facilities
Ventas, Inc. (NYSE: VTR) is a prominent player in the real estate investment trust (REIT) sector, focusing on creating and managing exceptional environments that cater to the needs of a rapidly growing aging population. With a substantial portfolio of approximately 1,350 properties across North America and the United Kingdom, the company plays a vital role in the longevity economy, which encompasses a broad range of industries and services designed to support the health, well-being, and quality of life of older adults. This portfolio is diversified across various asset classes, including senior housing communities, outpatient medical buildings, research centers, and healthcare facilities, allowing Ventas to leverage its expertise and resources to drive growth and deliver value to its stakeholders.
The company's senior housing communities, numbering over 800, are a key component of its growth strategy, providing a range of services and support to residents, from independent living to assisted living and memory care. These communities are designed to enable residents to thrive in supportive environments, with access to amenities, social activities, and healthcare services that promote physical and emotional well-being. By focusing on the needs of this demographic, Ventas is well-positioned to capitalize on the trends driving the longevity economy, including the increasing demand for age-friendly housing, healthcare services, and technologies that support healthy aging.
Ventas's ability to deliver outsized performance is underpinned by its operational expertise, data-driven insights from its Ventas OI platform, and extensive relationships with healthcare providers, operators, and other industry partners. The company's strong financial position and seasoned team of professionals also contribute to its success, with a shared commitment to excellence, integrity, and a common purpose of helping people live longer, healthier, and happier lives. As a leading S&P 500 company, Ventas is dedicated to creating long-term value for its shareholders, while also making a positive impact on the lives of its residents, patients, and the broader communities it serves.
With its common stock listed on the New York Stock Exchange (NYSE) under the ticker symbol VTR, Ventas is a publicly traded company that offers investors the opportunity to participate in the growth and development of the longevity economy. The company's ISIN, US92276F1003, and GICS Sub Industry classification as a Health Care REIT, provide additional context for investors seeking to understand its business model and investment profile. For more information about Ventas, Inc., including its portfolio, services, and commitment to excellence, please visit the company's website at https://www.ventasreit.com.
Additional Sources for VTR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VTR Stock Overview
Market Cap in USD | 25,133m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 1998-05-04 |
VTR Stock Ratings
Growth 5y | 32.9% |
Fundamental | 0.87% |
Dividend | 26.8% |
Rel. Strength Industry | 521 |
Analysts | 4.2/5 |
Fair Price Momentum | 54.63 USD |
Fair Price DCF | 48.26 USD |
VTR Dividends
Dividend Yield 12m | 3.06% |
Yield on Cost 5y | 3.86% |
Annual Growth 5y | -10.70% |
Payout Consistency | 97.3% |
VTR Growth Ratios
Growth Correlation 3m | -44.7% |
Growth Correlation 12m | 85.5% |
Growth Correlation 5y | 34.7% |
CAGR 5y | 4.73% |
CAGR/Mean DD 5y | 0.25 |
Sharpe Ratio 12m | 0.84 |
Alpha | -14.99 |
Beta | 1.51 |
Volatility | 22.58% |
Current Volume | 11491.5k |
Average Volume 20d | 3134.3k |
As of December 21, 2024, the stock is trading at USD 58.76 with a total of 11,491,486 shares traded.
Over the past week, the price has changed by -3.85%, over one month by -10.15%, over three months by -7.19% and over the past year by +20.14%.
Neither. Based on ValueRay Fundamental Analyses, Ventas is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 0.87 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VTR as of December 2024 is 54.63. This means that VTR is currently overvalued and has a potential downside of -7.03%.
Ventas has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy VTR.
- Strong Buy: 10
- Buy: 4
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, VTR Ventas will be worth about 60 in December 2025. The stock is currently trading at 58.76. This means that the stock has a potential upside of +2.13%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 70.7 | 20.4% |
Analysts Target Price | 50 | -14.9% |
ValueRay Target Price | 60 | 2.1% |